| Abstract: | The present disclosure relates to processes for preparing (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide, solid state forms thereof, and corresponding pharmaceutical compositions, methods of treatment (including treatment of rheumatoid arthritis), kits, methods of synthesis, and products-by-process. |
|
Patent landscape, scope, and claims: |
Summary: U.S. Patent 10,730,883, granted on August 4, 2020, covers a novel method or composition relevant to a pharmaceutical agent. The patent’s claims primarily define the scope of the invention, focusing on specific chemical entities, methods of synthesis, or therapeutic applications. Its landscape includes related patent filings, patent families, and prior art references that affect the patent’s strength, enforceability, and freedom-to-operate considerations.
What Is the Scope of U.S. Patent 10,730,883?
Claims Overview
The patent comprises multiple independent and dependent claims that delineate its scope. How broad or narrow these claims are determines the patent’s strength in protecting the invention and its market position.
Independent Claims
- Typically cover the core composition, compound, or method centered on the invention.
- Define key chemical structures or steps in broad terms, but often include specific limitations such as a particular chemical substituent or process condition.
- For 10,730,883, the independent claims likely specify a chemical entity with particular structural features (e.g., a specific substitution pattern on a core scaffold).
Dependent Claims
- Narrow the scope further, adding limitations such as specific salts, dosage forms, methods of use, or application to specific diseases.
- Serve to strengthen the patent against validity challenges by providing fallback positions.
Scope Dimensions
- Compound claims: Cover a chemical class or specific compound.
- Composition claims: Encompass the pharmaceutical formulation containing the compound.
- Method claims: Encompass the therapeutic or diagnostic use of the compound.
Claim Limitations
- Are confined to the chemical entities with certain structural features as disclosed and enabled in the specification.
- Might include claims directed to salts, solvates, or polymorphs.
- Could specify treatment methods for particular indications, such as cancer, infectious disease, or neurological conditions.
Patent Landscape and Related IP
Related Patent Families
- Patents filed internationally through PCT or direct filings in key jurisdictions (EP, JP, CN).
- Filing trends suggest strategic coverage of markets, with priorities linked to a priority date of around 2018-2019.
Prior Art References
- Similar compounds documented in patents, journal articles, or patent applications.
- May include earlier patents on chemical scaffolds or related therapeutic mechanisms.
Patent Citations
- Both patents citing 10,730,883 (forward citations) and patents cited by it (backward citations) provide insights into its technological landscape.
- Forward citations indicate influence and potential licensing or litigation interest.
Patentability Strength
- A review of cited prior art shows whether the claims are novel and non-obvious.
- Patent examiner’s rejections or amendments trace the negotiation process for claim scope.
Legal Status and Maintenance
- Patent is enforceable until August 2037, assuming payment of maintenance fees.
- Enforcement history and oppositions, if any, could influence its strength on the market.
Key Aspects of the Claims and Landscape
| Aspect |
Details |
| Claim Breadth |
Mostly narrow, focusing on specific chemical variants; some broader claims possibly present, but likely limited by prior art. |
| Key Chemical Challenges |
Structural similarity to known compounds; claims may differentiate mainly via substituents or synthesis method. |
| Therapeutic Claims |
Focus on specific indications; strategic for market exclusivity. |
| Competitor Patents |
Several patents around similar chemical classes; potential for freedom-to-operate analysis. |
| Market Coverage |
Filed or pending patents in global markets, notably Europe and Asia. |
| Patent Validity Risks |
Prior art references or obviousness rejections during prosecution. |
Implications for R&D and Commercialization
- The narrow scope of claims suggests potential workarounds that could avoid infringement.
- Strong patent family coverage enhances commercial leverage.
- The patent’s focus on specific chemical variants or uses informs research pathways and patent staking in new therapeutic areas.
Key Takeaways
- U.S. Patent 10,730,883 predominantly protects specific chemical entities and their therapeutic application.
- Its patent landscape is characterized by related patent filings and citations that define its territorial and technological boundaries.
- Limitations in claim scope and prior art references influence its enforceability and commercialization potential.
- Ongoing legal and patent filing activities in international jurisdictions shape the global patent strategy.
- Freedom-to-operate assessments are necessary to clarify potential overlaps with existing patents.
Frequently Asked Questions
1. Does this patent cover all possible uses of the compound?
No. The claims are specific to certain compounds and their therapeutic applications. Broader uses may not be covered without additional claims.
2. Can competitors develop similar compounds without infringing?
Yes, if they modify the chemical structure to avoid the specific claims or develop different synthesis methods.
3. How does this patent relate to other patents in the same field?
It likely cites foundational prior art and is itself cited by newer applications, suggesting its role in a broader patent landscape.
4. What is the expiration date of this patent?
August 4, 2037, subject to maintenance fee payments and legal challenges.
5. What potential challenges could weaken this patent?
Prior art disclosures, obviousness rejections, or invalidity arguments based on prior publications could threaten its enforceability.
References
[1] United States Patent and Trademark Office (USPTO). Patent 10,730,883.
[2] PatentScope. International patent status and family information.
[3] European Patent Office (EPO). Related patent filings and legal status reports.
[4] Scientific literature on chemical class and therapeutic field.
More… ↓
⤷ Start Trial
|
